St. Paul-based pharmaceutical company CNS Therapeutics named Andy LaFrence as its chief financial officer.
LaFrence was previously an audit partner at accounting firm KPMG.
"Andy's tremendous insight from the pharmaceutical, medical technology and financial markets is instrumental to our rapidly growing business," said CEO John Foster.
CNS Therapeutics received FDA approval last year for its generic version of a drug to treat severe spasticity.
Scott Bronson, the company's co-founder, is administrative and compliance officer. Bronson was previously CFO.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Star Tribune
Drone footage shows Ukrainian village battered to ruins as residents flee Russian advance
The Ukrainian village of Ocheretyne has been battered by fighting, drone footage shows. The village has been a target for Russian forces in Donetsk.
Election
In heated western Minn. GOP congressional primary, outsiders challenging incumbent
U.S. Rep. Michelle Fischbach has a solidly conservative voting record. But Steve Boyd, a Christian conservative who has never held public office, is gaining traction as an outsider.
Sports
Minnesota Sports Hall of Fame: A class-by-class list of all members
Who's in the Star Tribune Minnesota Sports Hall of Fame? From Bernie Bierman to the latest class, here's the list:
Sports
This retired journalist changed professional wrestling from Mankato
Norm Kietzer was a pioneer in professional wrestling journalism for 40 years.